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Genome-wide investigations of host–pathogen interactions are
often limited by analyses of mixed populations of infected and
uninfected cells, which lower sensitivity and accuracy. To over-
come these obstacles and identify key mechanisms by which Zika
virus (ZIKV) manipulates host responses, we developed a system
that enables simultaneous characterization of genome-wide tran-
scriptional and epigenetic changes in ZIKV-infected and neighbor-
ing uninfected primary human macrophages. We demonstrate
that transcriptional responses in ZIKV-infected macrophages dif-
fered radically from those in uninfected neighbors and that study-
ing the cell population as a whole produces misleading results.
Notably, the uninfected population of macrophages exhibits the
most rapid and extensive changes in gene expression, related to
type I IFN signaling. In contrast, infected macrophages exhibit a
delayed and attenuated transcriptional response distinguished by
preferential expression of IFNB1 at late time points. Biochemical
and genomic studies of infected macrophages indicate that ZIKV
infection causes both a targeted defect in the type I IFN response
due to degradation of STAT2 and reduces RNA polymerase II pro-
tein levels and DNA occupancy, particularly at genes required for
macrophage identity. Simultaneous evaluation of transcriptomic
and epigenetic features of infected and uninfected macrophages
thereby reveals the coincident evolution of dominant proviral or
antiviral mechanisms, respectively, that determine the outcome of
ZIKV exposure.
Zika virus | macrophage | immune evasion | genomics | transcription
Viruses survive and cause disease by avoiding and suppressinginnate and adaptive immune responses. Flaviviruses are
small, enveloped, single-stranded positive-sense RNA viruses
(1). They replicate using a viral RNA-dependent RNA poly-
merase that creates viral messenger RNA and new viral genomes
using a negative-sense RNA intermediate (2). More than 40
species of flaviviruses cause human disease, some associated with
extensive global morbidity and mortality. Most flaviviruses cause
acute infections and therefore must inhibit detection and eradi-
cation by the innate immune system. Flaviviruses have evolved
multiple mechanisms to inhibit innate immune responses. Improved
understanding of how these important pathogens subvert innate
immune responses could lead to novel strategies for the develop-
ment of antiviral agents.
Zika virus (ZIKV) is a member of the mosquito-borne group
of flaviviruses that are primarily transmitted by Aedes mosqui-
toes. ZIKV can also be also transmitted vertically from mother
to fetus and between sexual partners (1, 3–7). Based on the
presence of Aedes mosquitoes in nearly all tropical and sub-
tropical areas of the world, it is estimated that ∼3.6 billion
people worldwide are at risk for ZIKV infection (8, 9). Since
2007, ZIKV has caused outbreaks worldwide with documented
transmission in at least 84 countries (10). Although the precise
mechanisms are under investigation, there is strong evidence that
ZIKV causes life-threatening fetal brain abnormalities and Guil-
lain–Barré syndrome (11–15). ZIKV, like other human flaviviruses,
naturally infects innate immune cells, including monocytes and
macrophages (16). The ability to infect these cells is thought to
increase viral dissemination and contribute to pathogenesis.
However, how ZIKV infects macrophages and circumvents in-
nate immune activation is not well understood.
Due to the central importance of IFNs in antiviral responses,
most pathogenic viruses antagonize IFN production and/or IFN-
dependent response pathways directly (17). However, many viruses
also employ general host shut-off mechanisms that interfere with
RNA transcription, RNA processing, and/or translation to inhibit
host gene expression broadly (18, 19). This can both increase cel-
lular resources available for the production of viral products and
suppress host antiviral responses. To shut off host transcription,
some viruses inhibit RNA polymerase II (RNApol2), a large pro-
tein complex responsible for catalyzing the synthesis of mRNAs,
most snRNAs, and microRNAs (20–25). Although flaviviruses,
including ZIKV, are known to inactivate the IFN pathway at
multiple levels, none has been shown to inhibit transcription
globally (26).
Significance
Interpretation of genome-wide investigations of host–pathogen
interactions are often obscured by analyses of mixed populations
of infected and uninfected cells. Thus, we developed a system
whereby we simultaneously characterize and compare genome-
wide transcriptional and epigenetic changes in pure populations
of virally infected and neighboring uninfected cells to identify viral-
regulated host responses. Using patient-derived unmodified Zika
viruses (ZIKV) infecting primary human macrophages, we reveal
that ZIKV suppresses host transcription by multiple mechanisms.
ZIKV infection causes both targeted suppression of type I in-
terferon responses and general suppression by reducing RNA po-
lymerase II protein levels and DNA occupancy. Simultaneous
evaluation of transcriptomic and epigenetic features of infected
and uninfected cells provides a powerful method for identifying
coincident evolution of dominant proviral or antiviral mechanisms.
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Genome-wide investigations of ZIKV–macrophage interac-
tions have great potential to identify mechanisms by which ZIKV
modulates macrophage response in an unbiased manner. A
major limitation to understanding how ZIKV infects macro-
phages, or other cell types, is that the percentages of infected vs.
uninfected bystander cells in cultures vary widely. Thus, population-
level analyses are difficult to interpret because they include cells
that are not productively infected but could potentially respond to
signals from infected cells. Direct characterization of uninfected
cells in comparison with infected cells is therefore required to
disentangle proviral and antiviral responses and provide insights to
viral infections in vivo, in which only a small fraction of cells is
infected. Potential options to overcome this limitation include the
use of reporter viruses, highly susceptible cell lines, or single-cell
sequencing technologies. Reporter viruses help isolate infected
cells, but the insertion of reporter proteins into flaviviruses, which
are relatively small, may alter their virulence and prohibit studies
comparing wild-type patient-derived viruses. Studying susceptible
cell lines increases the percentage of infected cells within a pop-
ulation, but these cell lines often support robust viral replication
because they lack important antiviral signaling responses. Single-cell
profiling technologies are poised to circumvent many of these lim-
itations; however, many methods, including ChIP sequencing
(ChIP-seq), cannot yet be reliably applied at the single-cell
level. Additionally, single-cell RNA-sequencing (RNA-seq)
technologies that rely on oligo(dT) priming cannot distinguish
flavivirus-infected from uninfected cells, as these viruses do not
make polyadenylated RNA.
To overcome these obstacles, we developed an infection
model that enables the application of unbiased genome-wide
transcriptional and epigenetic analyses to identify how un-
modified clinical isolates of ZIKV modulate host responses in
pure populations of ZIKV-infected primary human macro-
phages, major cellular hosts of ZIKV, and other closely related
flaviviruses. We observed strikingly divergent transcriptional and
epigenetic responses between ZIKV-infected and uninfected by-
stander macrophages. Many of these differences would not be ap-
parent if the population of cells were studied as a whole. ZIKV
infection is associated with minimal gene activation and a nearly
complete loss of type I IFN signaling primarily resulting from ZIKV-
induced degradation of STAT2. In contrast, noninfected cells exhibit
robust activation of the type I IFN pathway. Additionally, ChIP-seq
of RNApol2 demonstrates that DNA occupancy is reduced
during ZIKV infection, leading to general suppression of tran-
scription and disproportionate loss of RNApol2 at core macro-
phage identity genes. This method of comparing genome-wide
transcriptomic and epigenomic responses in neighboring infected
and uninfected cells exposed to the same environment allows
deconvolution of the specific molecular mechanisms by which
ZIKV modulates macrophage responses.
Results
ZIKV Infection of Primary Human Macrophages. To study ZIKV–
macrophage interactions, we first developed an in vitro ZIKV
infection model that utilizes unmodified viruses to infect primary
human blood monocyte-derived macrophages (HMDMs). In-
fection of HMDMs with ZIKV FSS13025 (ZIKV FSS), an
Asian-lineage ZIKV human isolate from Cambodia (2010), at a
multiplicity of infection (MOI) of 1 (MOI1) resulted in only
1.5% infectivity on average at 24 h postinfection (PI) as mea-
sured by intracellular flow cytometry staining of the viral envelope
(E) protein using anti-flavivirus E protein (clone 4G2) (SI Ap-
pendix, Fig. S1A). Antibodies from individuals previously infected
with Dengue virus (DENV) can increase the infectivity of ZIKV
by antibody-dependent enhancement (ADE) (27–29). When HMDMs
were infected at the sameMOI1 but in the presence of humanDENV-
immune serum (ADE1), 40% of macrophages were infected on
average (SI Appendix, Fig. S1A). Even if the MOI was increased
to greater than 20 (high-MOI), ADE1 infection still resulted in
more infected macrophages than high-MOI conditions (SI Appen-
dix, Fig. S1A). ZIKV SD001 is an Asian-lineage virus isolated in San
Diego in 2016 during an acute ZIKV infection in a traveler returning
fromVenezuela. The frequency of infected HMDMs during infection
with ZIKV FSS and SD001 was not significantly different using
MOI1 or ADE1 conditions (SI Appendix, Fig. S1B). We next com-
pared the production of new infectious virus using MOI1, ADE1, or
high-MOI conditions by measuring the yield of secreted virus in
the culture supernatant by focus-forming unit (FFU) assay.
HMDMs infected by ADE1 produced 166-fold more infectious
ZIKV than infection by MOI1 and 60-fold more infectious ZIKV
than infection by high-MOI (SI Appendix, Fig. S1C). Compared
with ZIKV SD001, ZIKV FSS produced slightly higher infectious
titers at 24 h PI under ADE1 conditions (SI Appendix, Fig. S1D).
To determine ZIKV growth kinetics in HMDMs, we first mea-
sured the production of viral RNA under ADE1 conditions. We
detected intracellular ZIKV RNA starting at 8 h PI, with a rapid
increase in viral RNA levels occurring at 12–24 h PI (SI Appendix,
Fig. S1E). Intracellular staining of infected HMDMs using the
anti-flavivirus E protein antibody 4G2 first detected ZIKV
antigen-positive macrophages at 12 h PI (SI Appendix, Fig. S1F).
Between 12 and 24 h PI both the percentage of ZIKV+ macro-
phages and the intensity of 4G2 staining increase (SI Appendix,
Fig. S1F). Collectively, these results demonstrate robust ZIKV
replication in HMDMs under ADE1 conditions.
Divergent Transcriptional Responses in ZIKV-Infected and Bystander
Cells. To identify how ZIKV modulates macrophage responses,
we assessed genome-wide transcriptional responses in pure pop-
ulations of HMDMs. HMDMs were infected with ZIKV using
ADE1 conditions and were formaldehyde-fixed at different time
points PI. HMDMs were then stained intracellularly for the flavi-
virus E protein using 4G2 antibody and were separated by FACS
into infected ZIKV antigen-positive (ZIKV+) and uninfected ZIKV
antigen-negative (ZIKV−) populations. After reverse cross-linking
and protease digestion steps, high-quality total RNA was isolated
and analyzed using stranded rRNA-depleted total RNA-seq (Fig.
1A). Our approach successfully segregated ZIKV+ from ZIKV−
cells, as significant numbers of reads aligning to the ZIKV genome
were found only in the ZIKV+ populations (Fig. 1B). As expected,
the percentage of reads aligning to the ZIKV genome in ZIKV+
cells increased with time PI. By 24 h PI, more than 40% of all
mapped RNA-seq reads in ZIKV+ HMDMs aligned to the ZIKV
genome although the ZIKV genome is only ∼0.01% the size of all
human nonoverlapping exons (Fig. 1B).
We first compared the host transcriptomes of mock-infected
(medium alone), ZIKV+, and ZIKV− HMDMs using principal
component analysis (PCA). Even though each of the replicates
was performed with cells from different individuals, PCA grouped
replicates based on infection status and time point PI (Fig. 1C).
This close association among replicates suggests that interin-
dividual differences have less influence on the transcriptional
response of HMDMs than infection status and time point PI.
Strikingly, the first principal component (PC1) divided the data
into two groups, separating ZIKV−macrophages from ZIKV+ and
mock-infected HMDMs. This suggested that the transcriptional
responses of ZIKV+ macrophages were more similar to mock-
infected cells than to ZIKV− bystander cells (Fig. 1C). In fact,
when considering only PC1 and PC2, which captured 68% of the
overall transcriptomic differences between the samples, at 12 h PI,
the transcriptome of ZIKV+ HMDMs largely overlapped with
that of mock-infected macrophages. Only at later time points
did the transcriptomes segregate along PC2 based on time PI.
This suggests that ZIKV infection of macrophages, especially
at early time points PI, does not elicit a strong transcriptional
signature.
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Transcriptome studies of in vitro infections have typically
analyzed mixed populations of infected cells and uninfected
bystanders. To determine how a traditional mixed-population
transcriptome analysis would differ from our approach of iso-
lating and analyzing pure populations of ZIKV+ and ZIKV−
cells, we used our transcriptional profiles of pure ZIKV+ and
ZIKV− HMDM populations derived from five different indi-
viduals to simulate the transcriptional profiles of hypothetical
ZIKV-infected bulk populations over a range of 100–0% in-
fected cells (Fig. 1D). We used these simulated profiles to calcu-
late the recall rate of significantly changed genes identified in pure
ZIKV+ cells. In our analysis, as the fraction of infected cells de-
creased from 100%, the ability to identify genes specifically
repressed, and to a lesser degree induced, by ZIKV was lost
rapidly (Fig. 1D). Using our highly efficient macrophage in-
fection system, the average percent of infection at 24 h PI was
36%. Our model estimated that we would identify only 10% of
the repressed and 32% of the induced genes in a 36% ZIKV+
HMDM population (Fig. 1D). Examples of genes that were
induced by ZIKV that would have not been identified at 36%
infectivity included IL1A, EIF2AK3/PERK, ASAP2, and KLF4
(Fig. 1E and SI Appendix, Fig. S1G). Similarly, we would have
missed ZIKV-repressed genes such as CCR1, TNFRS11A, and
CCL2 (Fig. 1F and SI Appendix, Fig. S1H). In addition to de-
creased sensitivity in identifying genes regulated by ZIKV,
analysis of mixed populations can falsely identify genes as in-
duced or suppressed by ZIKV. At 36% infectivity, we estimated
that analysis of a mixed population would misidentify ∼600 genes
as induced and 300 genes as repressed by ZIKV (Fig. 1G). For
example, multiple inflammatory genes, including EIF2AK2/PKR,
IL6, and IFITM2 were strongly induced only in ZIKV− by-
stander cells. Mixed population analysis would suggest that these
genes were strongly up-regulated by ZIKV when in fact these
genes were not induced or in many cases were even suppressed in
cells productively infected with ZIKV (Fig. 1H and SI Appendix,
Fig. S1I).
In addition to improved discovery and accuracy, a major ad-
vantage of our infection model is the ability to analyze tran-
scriptional responses during infection with unmodified clinical
isolates. Using our method, we compared the response of
HMDMs during ADE1 infection with two ZIKV isolates derived
from human infections, ZIKV FSS and ZIKV SD001. These
strains infected the same percentage of HMDMs (SI Appendix,
Fig. S1B), with FSS infection producing slightly higher infectious
titers at 24 h PI (SI Appendix, Fig. S1D). The transcriptomes
of the uninfected bystander ZIKV− cells from the FSS and
SD001 infections were almost identical, with no genes called as
significantly different between these strains (SI Appendix, Fig. S1
J and K). In contrast, the transcriptomes of ZIKV+ macrophages
infected with either FSS or SD001 exhibited significant differ-
ences, pointing to biological differences between the virus strains
(SI Appendix, Fig. S1L). In ZIKV+ cells, 88 genes were expressed
at higher levels during SD001 infection than during FSS in-
fection, while 22 genes were expressed at significantly higher
levels during FSS infection than during SD001 infection (SI Ap-
pendix, Fig. S1K). Of these 110 genes, 71 genes were also signifi-
cantly up- or down-regulated compared with mock-infected cells (SI
Appendix, Fig. S1M). The set of genes down-regulated in ZIKV+
cells during FSS infection compared with SD001 infection and
mock treatment was enriched for multiple genes involved in RNA
processing and splicing, including the RNA helicases DDX5,
DDX17, and DDX42 and the splicing factors SRRM2 and SUGP2
(SI Appendix, Fig. S1N). As shown by our simulation above, tran-
scriptional analyses of mixed populations of ZIKV+ and ZIKV−
cells have especially poor sensitivity in detecting down-regulated
genes. We estimate that a mixed cell transcriptional analysis with
36% ZIKV+ cells would not identify 36 of the 46 genes specifically
down-regulated during FSS infection, including DDX5, DDX17,
DDX42, and SRRM2.
ZIKV Infection Elicits a Limited Transcriptional Response. To evaluate
ZIKV–macrophage interactions over time, we compared the
transcriptional responses in ZIKV+ and ZIKV− cells at 12, 18,
and 24 h PI to mock-infected HMDMs. ZIKV− cells up-
regulated a larger number of genes than ZIKV+ cells at 12 h
PI (420 genes in ZIKV− cells vs. 100 genes in ZIKV+ cells), 18 h
PI (708 in ZIKV− cells vs. 244 in ZIKV+ cells), and 24 h PI
(867 in ZIKV− vs. 657 in ZIKV+) (SI Appendix, Fig. S2A). While
some inflammatory genes were induced in ZIKV+ cells (exam-
ples include CXCL10, RSAD2, IFIT1, IFIT2, CXCL11, IFITM1,
IFI44L, CCL8, and TNFSF10/TRAIL), the degree of induction
was greater in ZIKV− bystander cells (SI Appendix, Fig. S2 B–D).
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Fig. 1. ZIKV modulates macrophage transcription during infection. (A) Di-
agram depicting the infection model. HMDMs are infected with ZIKV and
stained for ZIKV group antigen followed by FACS isolation of live, pro-
ductively infected ZIKV+ and bystander (ZIKV−) macrophages. (B) Percent of
RNA-seq reads aligning to the ZIKV genome in FACS-isolated ZIKV+ and
ZIKV−macrophages at the indicated time points PI. Percent was calculated as
the total reads aligning to ZIKV alone vs. human + ZIKV genomes. Each data
point (mean ± SEM) represents results from HMDMs derived from different
human donors. All categories were compared using ANOVA with correction
for multiple comparisons. (C) PCA biplot of the first two principal compo-
nent dimensions comparing RNA-seq of FACS-isolated ZIKV+ or ZIKV−
HMDMs from three (12 h and 18 h) or five (mock-infected and 24 h) indi-
vidual donors. (D) Calculated loss of sensitivity in detecting ZIKV-regulated
gene expression. Gene-expression levels were calculated using data from
ZIKV+, ZIKV−, and mock-infected macrophage RNA-seq experiments 24 h PI
performed with macrophages from five different donors. (E and F) Individ-
ual gene expression calculated by RNA-seq in pure populations of mock-
infected, ZIKV+, and ZIKV− macrophages (24 h PI). Mean (± SEM) IL1A (E)
and CCR1 (F) expressions of pure populations (black bars) were calculated
based on RNA-seq from five different donors. Mean (± SEM) expression of a
36% mixed population (white bar) was calculated computationally based on
mixing 36% ZIKV+ macrophages with 64% ZIKV− macrophages from each of
those five independent RNA-seq experiments. (G) Calculated number of
genes expected to be falsely attributed to ZIKV-dependent regulation based
on percent infectivity. Calculations were performed as in D. (H) Mean
(± SEM) EIF2AK2 and IL6 expression of pure populations (black bars) and a
36% mixed population (white bar) calculated as described in E and F.
E9174 | www.pnas.org/cgi/doi/10.1073/pnas.1807690115 Carlin et al.
However, as time PI increased, more uniquely up-regulated genes
were identified in ZIKV+ cells (SI Appendix, Fig. S2 C and D). For
example, at 18 h PI, ZIKV+ cells up-regulated AP1S3 and ASAP2,
involved in Golgi trafficking, and TNFRSF10D, a decoy TNF re-
ceptor that protects against TNFSF10/TRAIL-mediated apoptosis,
more than ZIKV− cells (SI Appendix, Fig. S2C). After 24 h of in-
fection, ZIKV+ cells up-regulated the gene encoding IFNβ, IFNB1,
and the transcription factor KLF4, involved in cell-cycle control,
more than their ZIKV− neighbors (SI Appendix, Fig. S2D).
ZIKV Suppresses Inflammatory Gene Activation in Macrophages. To
identify signaling pathways affected by ZIKV infection of mac-
rophages, we performed gene ontology and pathway analysis on
ZIKV− and ZIKV+ cells and compared them with mock-infected
HMDMs. At all time points ZIKV+ HMDMs showed a delayed
and diminished induction of genes from multiple inflammation
and immune response-related categories including IFN signaling,
cytokine signaling, antigen presentation, and pattern recognition
receptor (PRR) response pathways (Fig. 2 A and B). To identify
how ZIKV manipulates the transcriptional responses in HMDMs,
we identified the subset of genes uniquely induced in ZIKV+ cells
at 12, 18, and 24 h PI. The number of uniquely induced genes at
12 h PI in ZIKV+ cells was limited to only 36 genes. However,
these genes were significantly enriched for genes involved in
cholesterol biosynthesis, such as HMGCS1, MVD, MVK, and
SQLE (Fig. 2C). At 24 h PI, genes specifically induced in ZIKV+
macrophages were enriched for those involved in the unfolded
protein response, including the endoplasmic reticulum (ER)
stress response kinase EIF2AK3/PERK and the transcription
factor DDIT3/CHOP (Fig. 2C).
In addition to suppressed inflammatory gene induction, ZIKV+
macrophages also demonstrated increased down-regulation of
genes involved in multiple immune pathways, including leukocyte
activation/migration and cytokine signaling/secretion (SI Appendix,
A B
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Fig. 2. Degradation of STAT2 by ZIKV impairs ISG activation. (A) Heat maps of the top enriched functional annotations of genes significantly up-regulated
(fold change >2, FDR < 0.01) in ZIKV+ and ZIKV− macrophages compared with mock-infected macrophages at the indicated time points. (B) Heat map of the
relative expression of selected genes involved in cytokine signaling and antigen presentation in mock-infected, ZIKV+ and ZIKV− macrophages 24 h PI. Data
are the average of five experiments. (C) Venn diagrams showing the numbers of unique and shared up-regulated genes in ZIKV+ and ZIKV− macrophages
compared with mock-infected macrophages at 12, 18, and 24 h PI. The top significantly enriched functional category for genes uniquely induced in ZIKV+ cells
(red) at each time point is shown with examples of genes from that category. (D) Heat map depicting relative transcription of type I and III IFN genes and ISG
in ZIKV− and ZIKV+ macrophages vs. control (Mock) over time. Data are the average of three experiments (12 h and 18 h) or five experiments (24 h).
(E) Western blot of STAT1, phosphorylated-STAT1, STAT2, phosphorylated STAT2, ZIKV NS2B, and β-actin levels in equivalent numbers of mock-infected,
ZIKV−, and ZIKV+ cells at 24 h PI. (F) Relative quantitation of Western blot STAT2 levels in ZIKV− and ZIKV+ cells treated with MG132 or vehicle control (Mock).
STAT2 density is relative to β-actin. Data shown (mean ± SEM) are from three infections performed in HMDMs derived from three different individuals at 24 h
PI. Data were analyzed by ANOVA with MG132 treatment groups compared with vehicle with correction for multiple comparisons. (G) Relative gene ex-
pression in ZIKV− and ZIKV+ cells treated with MG132 compared with DMSO. Data (mean ± SEM) show the relative gene expression by qRT-PCR in at least
three independent experiments performed with FACS HMDMs derived from different donors at 24 h PI. Data for each gene were analyzed by ANOVA with
MG132-treatment groups compared with vehicle with correction for multiple comparisons. Asterisks indicate statistically significant differences (*P < 0.05).
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Fig. S2E). The top functional enrichment category for genes
specifically down-regulated in ZIKV+ cells at all time points was
histone deacetylases (HDACs) deacetylate histones (SI Appen-
dix, Fig. S2F). The second most enriched pathway in genes
uniquely down-regulated in ZIKV+ cells at 18 h PI was signaling
by interleukins. Down-regulated genes in this category include
multiple dual-specific protein phosphatases involved in regulating
MAPK signaling as well as receptors and chemokines involved in
immune activation. In ZIKV+ cells, there was specific down-regulation
of many inflammatory response genes at 24 h PI, including the PRR
signaling molecules CD14, TLR4, and LY96, cytokines such as CCL2
and CXCL8, and receptors such as C3AR1, C5AR1, and CCR1 (SI
Appendix, Fig. S2F).
ZIKV, like other human pathogenic flaviviruses, blocks IFN
induction of antiviral IFN-stimulated genes (ISGs). However,
the exact mechanisms by which and where in the IFN response
pathway ZIKV blocks ISG activation are not fully understood.
Moreover, the IFN response during flaviviral infections is highly
context-dependent and varies in a virus-, cell type-, and host
species-specific manner (30). Previous studies have demon-
strated that ZIKV may block the induction and/or translation of
IFNβ, thereby inhibiting the secretion of IFNs, and/or degrade
STAT2 and inhibit the phosphorylation of both STAT1 and
STAT2, which inhibits signaling downstream of the IFN α/β re-
ceptor and induction of ISGs (31–33). We therefore examined
the expression of IFN and ISG genes in ZIKV+ and ZIKV− cells
throughout ZIKV infection. ZIKV+ cells express type I and type
III IFN genes equivalently to ZIKV− cells at 12 and 18 h PI and
higher levels than ZIKV− cells at 24 h PI (Fig. 2D and SI Ap-
pendix, Fig. S2G). In contrast, ISG expression is markedly re-
duced in ZIKV+ cells compared with ZIKV− cells at 12, 18, and
24 h PI (Fig. 2D and SI Appendix, Fig. S2H). During ZIKV in-
fection of human dendritic cells, IFNs are induced at the tran-
scriptional level, but protein levels are not measurable in the
supernatants, suggesting impaired IFN protein production (31).
To determine if IFNβ is made and secreted following IFNB1
induction during ZIKV infection of macrophages, we measured
the IFNβ protein levels in supernatants by ELISA. We consis-
tently detected IFNβ in the supernatants of macrophages in-
fected with ZIKV at 24 h PI (SI Appendix, Fig. S2I). Collectively,
these data show that ZIKV broadly suppresses inflammatory
gene expression in infected macrophages. Type I and type III
IFN genes are induced in ZIKV+ macrophages, and IFNβ is
produced, but ZIKV+ macrophages demonstrate markedly re-
duced ISG induction compared with ZIKV− cells. This suggests
ZIKV blocks type I IFN signaling rather than type I IFN pro-
duction in macrophages.
ZIKV Degrades STAT2 to Inhibit Type I IFN Signaling in Macrophages.
To explore ZIKV inhibition of type I IFN signaling in macro-
phages, we first asked at which time point PI ZIKV inhibits IFN
signaling by treating ZIKV-infected HMDM cultures with ex-
ogenous type I IFN before infection or at multiple time points
PI. Exogenous IFN inhibited ZIKV infection in the HMDM
cultures when given at or before 4 h PI but not after 8 h PI (SI
Appendix, Fig. S3A). We next measured the kinetics of type I IFN
and ISG gene expression during ZIKV infection to determine
how rapidly these genes are up-regulated. Compared with mock-
infected cells, IFNB1 and ISGs, such as MX1, were consistently
up-regulated only at 8–12 h PI in ZIKV-infected HMDM cul-
tures (SI Appendix, Fig. S3 B and C). In contrast to IFNB1, which
is induced similarly in ZIKV+ and ZIKV− cells at 12 h PI, there
was no induction of MX1 in ZIKV+ cells (SI Appendix, Fig. S3 D
and E). These findings demonstrate that ZIKV blocks type I IFN
signaling in productively infected macrophages before IFNs can
stimulate ISG production.
To identify the potential mechanisms by which ZIKV inhibits
type I IFN signaling in macrophages, we examined levels of total
and phosphorylated STAT1 and STAT2 proteins in ZIKV+,
ZIKV−, and mock-infected control HMDMs. Western blots
demonstrated decreased STAT2 levels in ZIKV+ cells compared
with ZIKV− and mock-infected cells, consistent with STAT2
degradation (Fig. 2E and SI Appendix, Fig. S3F). We did not
detect STAT2 phosphorylation in either ZIKV+ or mock cells.
Levels of STAT1 were lower in ZIKV+ than in ZIKV− cells but
were not statistically different from levels in mock-infected
HMDMs (SI Appendix, Fig. S3G). Phosphorylated STAT1 was
detectable in both ZIKV+ and ZIKV− cells but not in mock-
infected cells (Fig. 2E and SI Appendix, Fig. S3F). Consistent
with the data described above suggesting blockade of downstream
IFN signaling early in infection, we observed (i) suppressed in-
duction of STAT1, an ISG, and STAT1 phosphorylation by 12 h PI
and (ii) up-regulation of STAT1 protein by 18 h PI in ZIKV− cells
compared with ZIKV+ cells (SI Appendix, Fig. S3 H–J).
Proteasome Inhibition Rescues STAT2 Degradation but Minimally
Restores ISG Induction. Studies using cell lines have shown that
ZIKV induces STAT2 degradation in a proteasome-dependent
manner and that treatment with a proteasome inhibitor can re-
store STAT2 levels (32, 33). Given that STAT2 is degraded by
ZIKV in human macrophages, we wanted to confirm that
inhibiting proteasome function would block the degradation of
STAT2 and additionally determine if this was sufficient to pro-
tect macrophages from ZIKV infection. We infected HMDMs
with ZIKV and allowed the virus to establish infection for 12 h.
We then added the proteasome inhibitor MG132 or DMSO
control and isolated ZIKV+ and ZIKV− macrophages 12 h later
(24 h PI) (SI Appendix, Fig. S3K). Addition of MG132, even at
12 h PI when ZIKV has inhibited IFN signaling, significantly,
increased STAT2 protein levels (Fig. 2F and SI Appendix, Fig.
S3L). However, while restoration of STAT2 levels by MG132 led
to significantly increased IFIT3 gene expression in ZIKV+ cells,
it did not increase MX1, CXCL10, IFI27, IFI6, and OAS3 ex-
pression (Fig. 2G).
ZIKV Degradation of STAT2 Suppresses the Genomic Activation
Landscape of Infected Cells. Signal-dependent transcription fac-
tors (SDTFs) play major roles in the regulation of gene expres-
sion by binding to distal enhancers (34). The activities of
transcription factors at enhancer elements can be inferred by
changes in H3K27ac, which correlates with transcriptional ac-
tivity (35). Therefore, motif analysis of genomic regions exhib-
iting gain or loss of H3K27ac can be used to infer the activity
states of the corresponding transcription factors in an unbiased
manner. To implement this approach, we performed ChIP-seq
for H3K27ac utilizing pure populations of ZIKV+ and ZIKV−
cells 24 h PI as well as mock-infected controls from three in-
dependent infections using HMDMs derived from three differ-
ent individuals (Fig. 3A).
Similar to the RNA-seq results that showed suppressed gene
induction, ZIKV+ macrophages had far fewer significantly up-
regulated H3K27ac peaks than ZIKV− cells (547 vs. 2,049 sig-
nificant peaks) (Fig. 3B). In contrast to ZIKV− cells, ZIKV+
macrophages had more significantly down-regulated H3K27ac
peaks than up-regulated peaks (Fig. 3B). Comparing H3K27ac in
ZIKV+ and ZIKV− cells identified many H3K27ac regions at
promoters and enhancers of genes that were specific to ZIKV−
cells. These included ISGs, such as OAS2 and members of the
IFITM family, as well as other inflammatory genes (Fig. 3 C and
D). Cis-regulatory elements marked exclusively by H3K27ac in
ZIKV+ cells were associated with genes involved in cell cycle,
cell differentiation, delayed senescence, and apoptosis inhibition
such as CDK6, BCL2, and KLF4 (Fig. 3C and SI Appendix, Fig.
S4A). Genome-wide analysis of promoter-distal H3K27ac peaks
demonstrated strikingly reduced enrichment of IFN regulatory
factor (IRF)/IFN-stimulated response element (ISRE) motifs in
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ZIKV+ cells (Fig. 3E). In contrast, although enriched to a much
lesser extent, NF-κB and STAT1 motifs were equally repre-
sented in promoter-distal H3K27ac peaks in ZIKV+ and ZIKV−
macrophages. Motifs for PU.1 and C/EBP, two macrophage
lineage-determining transcription factors (LDTFs), also showed
increased representation in distal H3K27ac peaks in ZIKV−
cells, likely reflecting their general requirement for binding of
SDTFs (34). Collectively, these results provide evidence that the
dominant transcriptional response of ZIKV− cells results from ac-
tivation of type I IFN signaling and suggest that this response is
impaired in ZIKV+ cells. STAT2 degradation in ZIKV+ cells leads
to inhibition of genomic activation of ISRE/IRF-containing en-
hancers and promoters, thereby broadly suppressing inflammatory
and ISG activation. These findings confirm and extend the litera-
ture by demonstrating that, in human macrophages, the type I IFN
system is the dominant anti-ZIKV mechanism and that type I IFN
signaling, rather than type I IFN production, is the major target of
ZIKV antagonism.
ZIKV Infection Reduces RNApol2 Protein Levels and DNA Occupancy,
Particularly at Genes Required for Macrophage Identity. The RNA
amounts recovered from ZIKV+ HMDMs were reproducibly lower
than the amounts recovered from the corresponding ZIKV− cells
[mean ZIKV+-to-ZIKV− ratio = 0.63, 95% CI (0.47–0.80)] (SI
Appendix, Fig. S4B). Although the majority of cellular RNA is
rRNA synthesized by RNApol1, we focused on RNApol2 because
this polymerase produces the majority of protein-coding transcripts
involved in antiviral responses. To determine the location and rel-
ative quantities of RNApol2 genome-wide, we performed ChIP-seq
for RNApol2 in equivalent numbers of pure populations of ZIKV+
and ZIKV− cells 24 h PI as well as in mock-infected controls (Fig.
4A). In three independent infections, using HMDMs derived
from three different individuals, we consistently detected less
RNApol2 at many locations across the genome in ZIKV+
macrophages than in ZIKV− macrophages (Fig. 4A and SI Ap-
pendix, Fig. S4C). To ensure that the lower RNApol2 ChIP levels in
ZIKV+ cells were not related to general problems performing
ChIP-seq in ZIKV+ cells, we performed ChIP-seq for the CCCTC-
binding factor (CTCF) transcription factor that is involved in
regulating chromatin structure. In contrast to RNApol2, the levels
of CTCF were roughly equivalent in both ZIKV+ and ZIVK− cells
(SI Appendix, Fig. S4D). RNApol2 levels were increased at IFNB1
and decreased at MX1, MX2, CXLC10, CCL8, and CCL2 in
ZIKV+ cells compared with ZIKV− cells, as expected (Fig. 4A and
SI Appendix, Fig. S4E). However, RNApol2 was also significantly
decreased at unexpected sites, such as CEBPB, and many snRNAs,
such as RNU4-2 and RNU4-1 (Fig. 4 A–C). Additionally, ZIKV+
cells exhibited significantly lower levels of RNApol2 at many genes
commonly associated with core macrophage functions such as the
LDTFs SPI1, CEBPB, and MAFB, peptidases MMP9, CTSD, and
CTSZ, lysozyme LYZ, ferritin light and heavy chain genes FTH1
and FTL, cell-surface receptors CD14 and CD68, and genes in-
volved in antigen processing, i.e., IFI30 and CD74 (Fig. 4D and SI
Appendix, Fig. S4F). Many of these genes are associated with
superenhancers (SEs) in HMDMs. SEs are regions of dispropor-
tionately high densities of active chromatin regulatory marks and
transcription factor binding close to genes that play essential roles in
the identity and function of cell types (36). While the majority of
genes have lower RNApol2 levels in ZIKV+ cells than in mock-
infected macrophages, genes associated with SEs demonstrated a
disproportionate reduction in RNApol2 signal (Fig. 4E).
RNApol2 is a large protein complex made up of 12 subunits.
The largest RNApol2 subunit, RPB1, contains the DNA-binding
domain of RNApol2 and a C-terminal domain that is essential
for regulating polymerase activity and associated processes. To
determine if the decreased RNApol2 ChIP-seq levels in ZIKV+
cells were associated with decreased RNApol2 protein levels, we
measured RPB1 levels in mock-infected, ZIKV−, and ZIKV+
cells. ZIKV+ cells had significantly lower levels of RPB1 protein
than ZIKV− and mock-infected control macrophages (Fig. 4 F
and G and SI Appendix, Fig. S4G). In contrast to RPB1 protein
levels, transcription of the gene POLR2A that encodes RPB1 was
significantly up-regulated in ZIKV+ cells compared with ZIKV−
and mock-infected control macrophages (Fig. 4H). While this
observation was similar to the discrepancy in STAT2 RNA and
protein levels induced by ZIKV, RPB1 levels did not normalize
after the addition of proteasome inhibitor, suggesting that ZIKV
employs a different mechanism to lower host cell RPB1 levels.
Collectively, these data demonstrate that productive ZIKV in-
fection reduces RNApol2 DNA occupancy globally but that this
effect is amplified at core macrophage genes, many of which are
associated with SEs.
Discussion
In these studies, we identify the genome-wide signaling networks
in primary human macrophages infected with ZIKV. We dem-
onstrate that neighboring ZIKV-infected and uninfected cells
have differing, often opposite, transcriptional responses that
obscure analyses of mixed populations in which uninfected cells
make up even a small percentage of the total population. Our
transcriptomic and epigenomic profiles of pure populations of
infected macrophages thus provide a more accurate map of the
human macrophage signaling response during ZIKV infection.
By comparing the transcriptomes and epigenomic features in
neighboring ZIKV+ and ZIVK− macrophages that are exposed
to identical environmental signals, the mechanisms employed by
ZIKV to subvert macrophage immunity are revealed. Impor-
tantly, our findings demonstrate that studying a mixed culture of
ZIKV-infected HMDMs would lead to the reasonable but erroneous
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conclusion that infection induces a type I IFN response when, in fact,
this response is restricted to cells that do not become productively
infected. The direct comparison of ZIKV+ and ZIKV− cells thus
provides important insights into the balance of pro- and antiviral
mechanisms and an unbiased assessment of the dominant regula-
tory pathways involved. This approach does not require viral
modification and can be performed in difficult-to-infect primary
human cells. Thus, it could be used to study genomic responses
during infection with any virus and to directly compare host–viral
interactions using clinical viral isolates in any cell type.
RNApol2 ChIP-seq in ZIKV+ and ZIKV− cells demonstrated
that RNApol2 DNA occupancy is disrupted in cells productively
infected with ZIKV. While RNApol2 levels are reduced at most
genes, the loss is especially pronounced at many genes associated
with SEs that play essential roles in macrophage identity and
function. Loss of RNApol2 DNA occupancy in ZIKV+ cells is
associated with decreases in protein levels of RPB1, the largest
RNApol2 subunit that plays critical roles in both DNA binding
and transcriptional elongation. Multiple pathogenic viruses, in-
cluding poliovirus, some Old World alpha viruses, influenza virus,
human herpesvirus 1, and Bunyamwera virus, inhibit RNApol2
during infection through either degradation or dephosphorylation
of RPB1, preventing transcription initiation or elongation, re-
spectively (20–24). Suppression of host transcription during viral in-
fection would increase the cellular resources available for viral
production and suppress host antiviral responses. The specific
mechanism by which ZIKV infection leads to decreases in
RPB1 and RNApol2 DNA occupancy and its effects on patho-
genesis remain to be elucidated. Significantly smaller and more
variable decreases in RNApol2 occupancy were also detected in
ZIKV− bystander cells compared with mock-infected cells. Why
this occurs in ZIKV− cells is unclear, but it may reflect a response
to secreted host or viral environmental signals. Although the exact
mechanisms of RNApol2 loss are still being identified, models of
CNS infection and infection of glioblastoma cells have suggested
that ZIKV causes loss of neural as well as cancer progenitor cells
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by blocking proliferation and inducing cell death (37, 38). Con-
ceivably, loss of RNApol2 in these cell types could contribute to
cell death in these tissues.
Our genome-wide studies of ZIKV infection in primary hu-
man macrophages demonstrate targeted suppression of ISRE/
IRF-dependent signaling networks that can be explained by
STAT2 degradation and are consistent with previous studies in
cell lines demonstrating that ZIKV NS5 protein degrades STAT2
in proteasome-dependent manner (32, 33). In macrophages,
proteasome inhibitor treatment given more than 4 h after ZIKV
has disabled cellular IFN signaling partially restored induction of
IFIT3 but not of other ISGs, such as MX1, CXCL10, IFI27, IFI6,
and OAS3. While all six of these ISGs have at least one ISRE
motif in their promoters [−300 to +100 bp from the transcription
start site (TSS)], only CXCL10 and OAS3 have NFκB motifs in
their promoters (SI Appendix, Fig. S4H). These and other antiviral
ISGs that are not partially rescued by MG132 may also be regu-
lated by NFκB at distal enhancer elements. Thus, although these
results could reflect gene-specific requirements for NFκB, which is
inhibited by proteosome blockade, they are also consistent with
the inhibitory effects of ZIKV on RNApol2.
ZIKV was discovered in 1947 and has caused sporadic human
infections for more than 50 y, but only during the recent outbreaks
in French Polynesia and South America was ZIKV associated with
congenital ZIKV syndrome and Guillain–Barré syndrome (13, 14,
39, 40). Although the specific mechanisms underlying this increased
human pathogenicity are still under investigation, it has been sug-
gested that evolution of the ZIKV genome may contribute to this
increasing virulence (41, 42). In support of this hypothesis, experi-
mental evidence has demonstrated strain-specific differences in viral
pathogenesis and neurologic disease in a STAT2-deficient mouse
model and single-amino acid substitutions that increase infectivity of
Aedes aegypti mosquitos and human and mouse neural progenitor
cells (43–45). Here, we performed genome-wide transcriptomic
analysis comparing human macrophage responses to two patient-
derived Asian ZIKV subtypes, SD001 and FSS. The specificity of
our system is demonstrated by the fact that when bystander ZIKV−
cells from SD001 and FSS infections are compared, we detect no
significant differences in gene regulation. In contrast, when ZIKV+
cells infected with SD001 or FSS are compared, 110 genes are
identified as being regulated in a strain-specific manner. The similar
transcriptional response in bystander ZIKV− cells during SD001
and FSS infections suggests that the bystander ZIKV− cells princi-
pally respond to secreted environmental signals such as IFNs and
cytokines and that these environmental signals are largely the same
during FSS and SD001 infections. Indeed our transcriptional anal-
ysis shows that the majority of cytokines/chemokines are made in
ZIKV− bystander cells. ZIKV+ cells also respond to environmental
stimuli, but their response is modified by viral activation and re-
pression of cellular response pathways. In the ZIKV+ populations,
strain-specific differences can influence how the virus activates or
represses these responses. In ZIKV+ cells, we identified differen-
tially expressed genes with functional enrichment for RNA pro-
cessing and RNA splicing and include multiple DEAD box RNA
helicases (DDX5, DDX17, and DDX42) that are down-regulated in
a strain-specific manner. Members of this protein family can act as
PRRs that recognize viral RNA and initiate antiviral responses.
Japanese encephalitis virus, another flavivirus, has been shown to
prevent DDX42 from activating type I IFN signaling (46, 47). Ad-
ditionally, RNA splicing is modulated by many human pathogenic
viruses, and ZIKV was recently shown to cause alternative splicing
events in infected neural progenitor cells (48). Given the accuracy of
our method and its ability to study differences between unmodified
patient-derived viruses in primary human cells, we anticipate that
future studies comparing numerous ZIKV strains could identify
key virulence mechanisms associated with viral genome evolution.
Although ZIKV largely suppresses inflammatory gene tran-
scription activation, genes associated with specific pathways are
selectively up-regulated in ZIKV+ cells. Genes involved in
cholesterol biosynthesis (HMGCS1, MVD, MVK, and SQLE),
ER/Golgi trafficking (AP1S3 and ASAP2), and cell survival
(TNFRSF10D and KLF4) are all induced in ZIKV+ macro-
phages and, based on previous data, have the potential to in-
crease ZIKV pathogenicity. Cholesterol synthesis plays critical
roles in flavivirus innate immune evasion and replication (49).
Flaviviruses bud into the ER lumen and require transport
through the trans-Golgi to form mature infectious particles and
viruses (50). Developing treatments that target these pathways
could prove efficacious, as evidenced by the fact that treatment
with the HMG-CoA reductase inhibitor lovastatin increased
survival rates in a mouse model of DENV-2 infection (51).
In summary, our work demonstrates that ZIKV manipulates
macrophage transcription at multiple levels. ZIVK specifically
inhibits type I IFN signaling and suppresses global transcription
by decreasing RNApol2 levels. Our method for identifying and
comparing genome-wide transcriptional and epigenetic changes
in neighboring infected and uninfected primary human macro-
phages using unmodified patient-derived viruses provides an
approach to allow rapid deconvolution of complex host–pathogen
interactions and directly compare the pathogenicity of clinical
viral isolates.
Methods
HMDM Isolation and Differentiation. Human blood for HMDM isolation was
obtained from healthy volunteers and was deidentified under the La Jolla
Institute Internal Review Board Protocol VD-057-0217. Donors were HIV,
hepatitis B, and hepatitis C negative. Human peripheral blood was separated
using Histopaque 1077 (catalog no. 10771; Sigma) spun at 400 × g for 30–
60 min at 4 °C. The buffy coat was washed once, and then the red blood cells
were lysed with molecular-grade water. Monocytes were then negatively
selected from the buffy coat using the pan monocyte isolation kit (catalog
no. 130-096-537; Miltenyi Biotech) as described by the manufacturer. Cells
were seeded onto tissue-coated plates and differentiated for 7 d in complete
macrophage medium [macrophage serum-free medium (catalog no. 12065;
Gibco) supplemented with 1% penicillin/streptomycin, 1% Nutridoma-SP
(catalog no. 11011375001; Roche), 1% fungizone (catalog no. 15290-018;
Gibco), and 100 ng/mL human macrophage-colony stimulating factor (M-
CSF) (catalog no. 300-25; PeproTech)] at 37 °C, 5% CO2. The medium was
changed every 2–3 d.
ZIKV Infection and Treatments. On day 7 of culture, macrophages were in-
fected with Zika virus clinical isolates SD001 or FSS13025 at the indicated MOI
with or without ADE [MOI = 1 + 0.6% (vol/vol) DENV human immune serum].
The virus was incubated with HMDMs for 2 h at 37 °C, 5% CO2 with rocking
every 10–15 min. The supernatant was removed, and cells were washed
three times with 1× PBS, before the addition of fresh warm complete
macrophage medium. Both RNA-seq and flow cytometry confirmed that no
infectious DENV was present in the human immune serum. When indicated,
HMDMs were treated with 1,000 U of universal type I IFN (PBL Assay Sci-
ence), 10 μM MG132, or carrier controls at the indicated time points.
Quantification of Infected HMDMs by Flow Cytometry. HMDMs were lifted by
gentle cell scraping (catalog no. 83.1830; Sarstedt) into PBS. Cells were
washed once with FACS buffer (1× PBS, 3% FBS, and 2 mM EDTA). Cells were
fixed and permeabilized with BD Cytofix/Cytoperm (BD Biosciences) and
washed with BD Perm/Wash Buffer per the manufacturer’s instructions.
Samples were blocked with Human Fc block (BioLegend) in BD Perm/Wash
Buffer for 10 min and were incubated with 4G2-AF647–conjugated antibody
for 30 min. Samples were washed twice with BD Perm/Wash Buffer followed
by resuspension in FACS buffer and were analyzed by flow cytometry on a
BD LSRII flow cytometer.
Quantitation of Virus Production by FFU. Baby hamster kidney cells (BHKs)
were seeded at 1–2E5 cells per well in a 24-well plate overnight. Super-
natants harvested from infection experiments were serial diluted, added to
BHKs, and incubated for 2 h with rocking. Supernatant was aspirated, and
1 mL of prewarmed carboxymethyl cellulose (CMC) medium (MEM-alpha
containing 1% CMC, 1% Hepes, and 2% FBS) was added. At 2–3 d PI, 1 mL
of 4% formalin was added directly to the CMC medium and was incubated
for 30 min at room temperature. Cells were washed three times with 1× PBS,
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permeabilized with 1% Triton X-100, washed, blocked with 10% FBS, and
stained with 4G2 primary antibody (1 μg/mL) supplemented with 1% FBS.
Wells were washed with 1× PBS and stained with HRP-conjugated secondary
antibody supplemented with 1% BSA at room temperature. Cells were
washed three times with 1× PBS, and 0.2 mL of TrueBlue (SeraCare) was
added and incubated for 20 min at room temperature or until foci became
apparent. Plates were then washed and dried, and FFU were counted.
Viral RNA Quantitation by qRT-PCR. Total RNA was isolated using the RNeasy
Mini Kit (74106; Qiagen) as described by the manufacturer. A one-step qPCR
was performed using ZIKV primers 853F: 5′-TTGGTCATGATACTGCTGATTGC-
3′ and 911R: 5′-CCTTCCACAAAGTCCCTATTGC-3′ and 18S rRNA primers R: 5′-
GCTGGAATTACCGCGGCT-3′ and F: 5′-CGGCTACCACATCCAAGGAA-3 using a
Bio-Rad qRT-PCR Thermocycler. Viral RNA concentration was determined
based on an internal standard curve composed of five 100-fold serial dilu-
tions of in vitro-transcribed RNA from ZIKV strain FSS13025 and normalized
to 18S rRNA.
STAT1 Flow Cytometry Analysis. Macrophages were lifted by gentle cell
scraping (catalog no. 83.1830; Sarstedt) into PBS, washed once with PBS, and
incubated with Zombie live/dead stain (BioLegend) at 4 °C. After washing,
cells were fixed in 4% formaldehyde, washed, and permeabilized in 90% ice-
cold methanol. Samples were washed and blocked with Human Fc Block for
10 min at 4 °C followed by 30-min incubation at 4 °C with directly conju-
gated 4G2-AF647, AF488-Phospho-Stat1 (Tyr701) (58D6), PE-Stat1 (D1K9Y),
or isotype controls (Cell Signaling). Samples were centrifuged, washed twice
with PBS + 0.5% BSA, and analyzed by flow cytometry on a BD LSRI
flow cytometer.
Separation of Infected and Uninfected Cells by FACS for RNA-Seq. Macro-
phages were washed once with 1× PBS, gently scraped off in 1× PBS, pelleted
at 4 °C, and stained with Zombie Violet viability dye (BioLegend) in the dark.
Cells were washed once with FACS buffer (1× PBS, 3% FBS, and 2 mM EDTA)
and were fixed and permeabilized with 4% paraformaldehyde (15710-S;
Electron Microscopy Sciences) and 0.1% saponin (47036; Sigma-Aldrich) in
molecular-grade PBS supplemented with 1:100 RNasin Plus RNase Inhibitor
(N2615; Promega) for 30 min at 4 °C. Cells were washed in wash buffer (1×
PBS containing 0.2% BSA, 0.1% saponin, and 1:100 RNasin Plus RNase in-
hibitor) and were blocked for 10 min with human Fc Block (1:500) (BioLegend)
in staining buffer (1× PBS containing 1% BSA, 0.1% saponin, and RNasin Plus
RNase inhibitor). HMDMs were then stained with 4G2 antibody (BioXcell)
conjugated to AF647 (catalog no. A20186; Thermo Scientific) for 30 min at
4 °C, washed twice, resuspended at 5–10E6 cells/mL in sort buffer (PBS con-
taining 0.5% BSA and 1:25 RNasin Plus RNase inhibitor) and sorted into ZIKV+
and ZIKV− cells on a FACSAria cell sorter (BD Biosciences) at the La Jolla In-
stitute for Allergy and Immunology. Gates were set with reference to
negative controls.
RNA Isolation and Library Preparation. After sorting, cells were pelleted at
4 °C, the supernatant was discarded, and total RNA was isolated using the
RecoverAll Total Nucleic Acid Isolation Kit (AM1975; Ambion), starting at the
protease digestion step. All steps were performed per the manufacturer’s
recommendations with the following modification. Cells were incubated in
digestion buffer for 3 h at 50 °C supplemented with RNasin Plus RNase inhibitor.
RNA was treated with in-column DNase per the manufacturer’s instructions and
was eluted; RNA quality was determined by BioAnalyzer using the Eukaryote
Total RNA Pico Chip. Samples with RNA integrity number (RIN) values greater
than 8.0 were used for library preparation. RNA libraries were generated using
the TruSeq stranded total RNA-seq kit (Illumina) per the manufacturer’s in-
structions and were single-end sequenced for 51 cycles on an Illumina Hi-Seq
2000 or NextSeq 500 system per the manufacturer’s instructions.
ChIP. For ChIP-seq experiments, HMDMs were cross-linked with 1% formal-
dehyde for 15 min in the presence of 1 mM sodium butyrate and were
quenched with 0.125 M glycine. Preparation of HMDMs for FACS was per-
formed as described above for RNA-seq except that 1× cOmplete protease
inhibitors (Roche) and 1 mM sodium butyrate (Sigma) were included in all
buffers instead of RNasin Plus RNase inhibitor. Following FACS, cells were
washed, pelleted, and snap-frozen. ChIP for histone modification H3K27ac
was performed as previously described (52). Sequencing libraries were pre-
pared from recovered DNA (ChIP) using the NEBNext Ultra II DNA library
prep kit (New England Biolabs) using NEXTflex DNA Barcodes (Bioo Scientific).
ChIP-seq libraries were single-end sequenced for 51 cycles on an Illumina HiSeq
4000 or NextSeq 500 system according to the manufacturer’s instruction.
Western Blot. HMDMs were processed as described in the ChIP-seq protocol
above except that cOmplete protease inhibitors (Roche) and PhosSTOP
phosphatase inhibitors (Sigma) were included in all buffers. Following
FACS, equal numbers of cells were aliquoted for each condition and were
lysed using RIPA buffer. Samples were then boiled in Laemmli Sample Buffer
(Bio-Rad) for 5–10 min. Protein lysates were separated by 10% SDS/PAGE,
electrophoretically transferred to a nitrocellulose membrane, and immuno-
blotted at 4 °C overnight with antibodies (1:1,000) against STAT1, STAT1-P,
β-actin (Cell Signaling Technology), and NS2B (GTX133308; GeneTex).
Membranes were then incubated with an HRP-conjugated second antibody
(1:10,000) for 1 h at room temperature followed by detection by enhanced
chemiluminescence (Bio-Rad).
ELISA. Supernatants from mock- or ZIKV-infected HMDMs were removed, ali-
quoted, snap-frozen, and stored at −80 °C. Aliquots were treated as single-use
and did not undergo freeze–thaw cycles. Samples were diluted in sample buffer,
and IFN-β ELISA was performed per the manufacturer’s instructions using the
VeriKine high-sensitivity human IFN-β serum ELISA kit (PBL Assay Science).
qPCR. Total RNA was isolated from unsorted cells using the Quick-RNA
isolation kit (Zymo), with in-column DNase digestion per the manufac-
turer’s instructions. RNA from FACS-isolated cells was prepared as de-
scribed above for the RNA-seq experiments. RNA was converted to cDNA
by reverse transcription using the SuperScript III First-strand synthesis kit
(Invitrogen). qPCR (SYBR GreenER SuperMix kit; Bio-Rad) analysis was
performed on an Applied Biosystems 7300 Real-time PCR system (Invitrogen)
using the following primers: RPLP0 forward 5′-GTGTTCGACAATGGCAGCAT-
3′; RPLP0 reverse 5′-GACACCCTCCAGGGAGCGA-3′; IFNB1 forward 5′-AG-
TAGGCGACACTGTTCGTG-3′; IFNB1 reverse 5′-GCCTCCCATTCAATTGCCAC-3′;
IFIT3 forward 5′-TCAGAAGTCTAGTCACTTGGGG-3′; IFIT3 reverse 5′-ACA-
CCTTCGCCCTTTCATTTC-3′; MX1 forward 5′-GTGGCTGAGAACAACCTGTG-3′;
MX1 reverse 5′-GGCATCTGGTCACGATCCC-3′.
Data Processing.
Preprocessing. FASTQ files from sequencing experiments were mapped to the
University of California, Santa Cruz (UCSC) genome build hg38 (for human)
and access KU955593.1 (for the ZIKV genome). STAR with default parameters
was used tomap RNA-seq experiments. Bowtie2 with default parameters was
used to map ChIP-seq experiments. HOMER was used to convert uniquely
aligned reads into tag directories for further analysis.
RNA-seq. RNA-seq reads aligned to a combined GRCh38/hg38 and ZIKV ge-
nome were used to calculate the percentage of reads aligned to the ZIKV
genome: [(number of reads aligned to the ZIKV genome/number of reads
aligned to hg38+ZIKV genomes) × 100 − the average number of reads
aligning to the ZIKV genome in mock-infected cells]. RNA-seq reads aligned to
the GRCh38/hg38 assembly were used to generate gene expression FPKM
(fragments per kilobase of transcript per million mapped reads) values using
HOMER (53). Genes with less than 0.5 FPKM in all conditions were defined as not
expressed. To measure gene expression, HOMER’s analyzeRepeats.pl utility was
used to quantify reads in transcript exons defined by GENCODE. Differentially
expressed genes and regularized logarithm (rlog) normalization values for each
gene were calculated using DESeq2while accounting for individual donors in the
design matrix. Functional enrichment calculations were performed using Meta-
scape (54), and promoter DNA motif enrichment calculations were performed
using HOMER (53). Enrichment values (logP) were clustered using Cluster 3.0 (55)
and were visualized using Java TreeView (56). PCA was performed in R (57). In
silico modeling of the detection of differentially expressed genes in mixed by-
stander/infected populations was performed by proportionally blending gene-
based read counts from each ZIKV− (bystander) and ZIKV+ RNA-seq replicate
experiment into a single mixed experiment for each donor and repeating the
differential expression calculations using DESeq2. This was repeated for different
fractions of ZIKV+ cells (every 5%) and compared with the lists of differentially
expressed genes derived from the pure sorted populations.
ChIP-seq. ChIP-seq peaks were called on the tags from pooled experiments in
each condition with the input DNA as background using HOMER’s findPeaks
command using the -style histone (H3K27ac) or -style factor (RNApol2/CTCF)
options and were merged using the mergePeaks command. To get differ-
entially bound peaks, tags were counted across the merged peak set for
each replicate experiment and analyzed using DESeq2, accounting for
donor-matched samples in the design matrix [twofold difference and false-
discovery rate (FDR) <0.01]. Motif finding in promoter-distal H3K27ac re-
gions (>3 kb from the TSS) was performed using the findMotifsGenome.pl
command using a region size of 1,000 bp. SEs were called using HOMER on
pooled H3K27ac samples for mock-infected, ZIKV−, and ZIKV+ conditions.
Putative H3K27ac peaks within 12,500 bp were stitched together during SE
E9180 | www.pnas.org/cgi/doi/10.1073/pnas.1807690115 Carlin et al.
calling, and peaks overlapping GENCODE-defined promoter regions were
excluded during this step. RNApol2-defined expression levels were calculated
by treating RNApol2 ChIP-seq data as unstranded RNA-seq and quantifying
gene-body FPKM values using HOMER’s analyzeRepeats.pl script.
Statistical Analysis. Statistical analysis was conducted using GraphPad Prism 7
(GraphPad Software) using the recommended multiple comparison test.
Values of P < 0.05 were considered significant.
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